Benzinga | Oct 19, 2020 07:43AM EDT

Piper Sandler Maintains Overweight on Agios Pharmaceuticals, Lowers Price Target to $73

Piper Sandler maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Overweight and lowers the price target from $80 to $73.